Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POET: Prophylactic Oral Antibiotics in Pituitary Surgery
NCT03014687Phase 4Recruiting
- Sponsor
- St. Joseph's Hospital and Medical Center
- Start
- Jul 2017
- Primary completion
- Jan 2019
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of cefdinir, trimethoprim + sulfamethoxazole in Bacterial sinusitis (BRS), sponsored by St. Joseph's Hospital and Medical Center. Started Jul 2017; status: recruiting.
02
Drugs
cefdinirtrimethoprim + sulfamethoxazole
03
Conditions
Bacterial sinusitis (BRS)
Beyond the preview
Go deeper on NCT03014687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03014687.